Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Venous thromboembolism in chronic pediatric heart disease is associated with substantial health care burden and expenditures.

Woods GM, Boulet SL, Texter K, Yates AR, Kerlin BA.

Res Pract Thromb Haemost. 2019 May 17;3(3):372-382. doi: 10.1002/rth2.12205. eCollection 2019 Jul.

2.

Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.

Kumar R, Harsh K, Saini S, O'Brien SH, Stanek J, Warren P, Giver J, Go MR, Kerlin BA.

J Pediatr. 2019 Apr;207:226-232.e1. doi: 10.1016/j.jpeds.2018.11.018. Epub 2018 Dec 7.

3.

Inpatient Health Care Utilization in Children With Hemophilia Before and After the Joint Outcome Study Publication.

Drayton Jackson M, O'Brien SH, Stanek J, Dunn AL, Kerlin BA.

J Pediatr Hematol Oncol. 2019 Jul;41(5):e284-e289. doi: 10.1097/MPH.0000000000001329.

PMID:
30339654
4.

Variation in Platelet Delta Granules Over Time in Young Women Undergoing Evaluation for Heavy Menstrual Bleeding.

Woods GM, Pillay Smiley N, Stanek J, Kahwash S, Kerlin BA, O'Brien SH.

Pediatr Dev Pathol. 2019 Mar-Apr;22(2):123-127. doi: 10.1177/1093526618803838. Epub 2018 Oct 9.

PMID:
30301444
5.

Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome.

Carpenter SL, Goldman J, Sherman AK, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Smoyer WE, Kerlin BA, Rheault MN.

Pediatr Nephrol. 2019 Feb;34(2):261-267. doi: 10.1007/s00467-018-4072-6. Epub 2018 Sep 7.

6.

State of the art in factor XIII laboratory assessment.

Durda MA, Wolberg AS, Kerlin BA.

Transfus Apher Sci. 2018 Dec;57(6):700-704. doi: 10.1016/j.transci.2018.07.006. Epub 2018 Aug 4. Review.

PMID:
30087086
7.

Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency.

Carcao M, Altisent C, Castaman G, Fukutake K, Kerlin BA, Kessler C, Lassila R, Nugent D, Oldenburg J, Garly ML, Rosholm A, Inbal A.

Thromb Haemost. 2018 Mar;118(3):451-460. doi: 10.1055/s-0038-1624581. Epub 2018 Feb 15.

8.

Thrombosis of the Abdominal Veins in Childhood.

Kumar R, Kerlin BA.

Front Pediatr. 2017 Sep 5;5:188. doi: 10.3389/fped.2017.00188. eCollection 2017. Review.

9.

Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience.

Woods GM, Stanek J, Harrison S, Texter K, Kerlin BA, Dunn AL, Kumar R.

J Pediatr Hematol Oncol. 2017 Oct;39(7):576-577. doi: 10.1097/MPH.0000000000000966. No abstract available.

PMID:
28902081
10.

Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.

Kerlin BA, Inbal A, Will A, Williams M, Garly ML, Jacobsen L, Kearney SL.

J Thromb Haemost. 2017 Aug;15(8):1601-1606. doi: 10.1111/jth.13748. Epub 2017 Jul 10.

11.

Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.

Sharma R, Waller AP, Agrawal S, Wolfgang KJ, Luu H, Shahzad K, Isermann B, Smoyer WE, Nieman MT, Kerlin BA.

J Am Soc Nephrol. 2017 Sep;28(9):2618-2630. doi: 10.1681/ASN.2016070789. Epub 2017 Apr 19.

12.

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A-LONG and Kids A-LONG Studies.

Quon DV, Klamroth R, Kulkarni R, Shapiro AD, Baker RI, Castaman G, Kerlin BA, Tsao E, Allen G.

Haemophilia. 2017 Jan;23(1):e39-e42. doi: 10.1111/hae.13125. Epub 2016 Dec 11. No abstract available.

PMID:
27943467
13.

Light Transmission Aggregometry Does Not Correlate With the Severity of δ-Granule Platelet Storage Pool Deficiency.

Woods GM, Kudron EL, Davis K, Stanek J, Kerlin BA, O'Brien SH.

J Pediatr Hematol Oncol. 2016 Oct;38(7):525-8. doi: 10.1097/MPH.0000000000000638.

PMID:
27403770
14.

The emerging role of coagulation proteases in kidney disease.

Madhusudhan T, Kerlin BA, Isermann B.

Nat Rev Nephrol. 2016 Feb;12(2):94-109. doi: 10.1038/nrneph.2015.177. Epub 2015 Nov 23. Review.

15.

Validation Study of the Composite Score to Identify Von Willebrand Disease in Children.

Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, Kulkarni R, Gupta S, Gunawardena S, Kouides PA, Brown D, Ragni MV.

J Pediatr Hematol Oncol. 2016 Mar;38(2):139-42. doi: 10.1097/MPH.0000000000000460.

PMID:
26535774
16.

An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

Li B, Luo X, Deng B, Wang J, McComb DW, Shi Y, Gaensler KM, Tan X, Dunn AL, Kerlin BA, Dong Y.

Nano Lett. 2015 Dec 9;15(12):8099-107. doi: 10.1021/acs.nanolett.5b03528. Epub 2015 Nov 6.

17.

AKI in Children Hospitalized with Nephrotic Syndrome.

Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE; Midwest Pediatric Nephrology Consortium.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2110-8. doi: 10.2215/CJN.06620615. Epub 2015 Oct 8.

18.

A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents.

Woods GM, Kerlin BA, O'Brien SH, Bonny AE.

J Pediatr Adolesc Gynecol. 2016 Oct;29(5):402-408. doi: 10.1016/j.jpag.2015.05.007. Epub 2015 May 30. Review.

PMID:
27491960
19.

Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Kerlin BA, Waller AP, Sharma R, Chanley MA, Nieman MT, Smoyer WE.

J Am Soc Nephrol. 2015 Dec;26(12):3009-19. doi: 10.1681/ASN.2014111097. Epub 2015 Apr 8.

20.

Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.

Brand-Staufer B, Carcao M, Kerlin BA, Will A, Williams M, Tornøe CW, Sandberg Lundblad M, Nugent D.

Haemophilia. 2015 May;21(3):380-5. doi: 10.1111/hae.12616. Epub 2015 Jan 21.

PMID:
25643920
21.

Development of a pediatric-specific clinical probability tool for diagnosis of venous thromboembolism: a feasibility study.

Kerlin BA, Stephens JA, Hogan MJ, Smoyer WE, O'Brien SH.

Pediatr Res. 2015 Mar;77(3):463-71. doi: 10.1038/pr.2014.198. Epub 2014 Dec 17.

22.

Healthcare burden of venous thromboembolism in childhood chronic renal diseases.

Kerlin BA, Smoyer WE, Tsai J, Boulet SL.

Pediatr Nephrol. 2015 May;30(5):829-37. doi: 10.1007/s00467-014-3008-z. Epub 2014 Dec 7.

23.

Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Rheault MN, Wei CC, Hains DS, Wang W, Kerlin BA, Smoyer WE.

Pediatr Nephrol. 2014 Jan;29(1):139-47. doi: 10.1007/s00467-013-2607-4. Epub 2013 Sep 14.

24.

Venous thromboembolism in pediatric nephrotic syndrome.

Kerlin BA, Haworth K, Smoyer WE.

Pediatr Nephrol. 2014 Jun;29(6):989-97. doi: 10.1007/s00467-013-2525-5. Epub 2013 Jun 28. Review.

25.

Current and future management of pediatric venous thromboembolism.

Kerlin BA.

Am J Hematol. 2012 May;87 Suppl 1:S68-74. doi: 10.1002/ajh.23131. Epub 2012 Feb 24. Review.

26.

Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.

Kerlin BA, Ayoob R, Smoyer WE.

Clin J Am Soc Nephrol. 2012 Mar;7(3):513-20. doi: 10.2215/CJN.10131011. Epub 2012 Feb 16. Review.

27.

The PFA-100 ® does not predict delta-granule platelet storage pool deficiencies.

Sladky JL, Klima J, Grooms L, Kerlin BA, O'Brien SH.

Haemophilia. 2012 Jul;18(4):626-9. doi: 10.1111/j.1365-2516.2011.02733.x. Epub 2012 Jan 8.

PMID:
22226191
28.

Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases.

Setty BA, O'Brien SH, Kerlin BA.

Pediatr Blood Cancer. 2012 Aug;59(2):258-64. doi: 10.1002/pbc.23388. Epub 2011 Oct 28.

29.

Pulmonary morbidity of catheter-related pediatric venous thromboembolism: old problem, new worry.

Kerlin BA.

Crit Care Med. 2011 May;39(5):1234-5. doi: 10.1097/CCM.0b013e318211fa25. No abstract available.

PMID:
21610596
30.

Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.

Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA.

Ann Thorac Surg. 2010 Feb;89(2):570-6. doi: 10.1016/j.athoracsur.2009.11.023.

PMID:
20103344
31.

Thrombolysis for pediatric venous thromboembolism: is it time for a trial?

Kerlin BA.

Pediatr Blood Cancer. 2009 Dec;53(6):920-1. doi: 10.1002/pbc.22195. Review. No abstract available.

PMID:
19637329
32.

Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study.

Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE.

J Pediatr. 2009 Jul;155(1):105-10, 110.e1. doi: 10.1016/j.jpeds.2009.01.070. Epub 2009 Apr 24.

33.

Social and ethical controversies in thrombophilia testing and update on genetic risk factors for venous thromboembolism.

Varga EA, Kerlin BA, Wurster MW.

Semin Thromb Hemost. 2008 Sep;34(6):549-61. doi: 10.1055/s-0028-1103366. Epub 2008 Nov 28. Review.

PMID:
19085654
34.

Desmopressin responsiveness in children with Ehlers-Danlos syndrome associated bleeding symptoms.

Mast KJ, Nunes ME, Ruymann FB, Kerlin BA.

Br J Haematol. 2009 Jan;144(2):230-3. doi: 10.1111/j.1365-2141.2008.07446.x. Epub 2008 Nov 19.

PMID:
19036109
35.

Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population.

Hyatt SA, Wang W, Kerlin BA, O'Brien SH.

Pediatr Blood Cancer. 2009 Jan;52(1):102-7. doi: 10.1002/pbc.21755.

PMID:
18816699
36.

Congenital amegakaryocytic thrombocytopenia: the diagnostic importance of combining pathology with molecular genetics.

Rose MJ, Nicol KK, Skeens MA, Gross TG, Kerlin BA.

Pediatr Blood Cancer. 2008 Jun;50(6):1263-5. doi: 10.1002/pbc.21453.

PMID:
18240171
37.

Fibrinogen Columbus: a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophilia.

Davis RL, Mosesson MW, Kerlin BA, Canner JA, Ruymann FB, Brennan SO.

Haematologica. 2007 Aug;92(8):1151-2.

38.

Recommendations for screening for thrombophilic tendencies in teenage females prior to contraceptive initiation.

Savelli SL, Kerlin BA, Springer MA, Monda KL, Thornton JD, Blanchong CA.

J Pediatr Adolesc Gynecol. 2006 Aug;19(4):313-6. Review. No abstract available.

PMID:
16873040
39.

Concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia.

Greenbaum LA, Kerlin BA, Van Why S, Punzalan RC, Trost BA, Pan CG, Scott JP.

Pediatr Nephrol. 2003 Dec;18(12):1301-3. Epub 2003 Oct 30.

PMID:
14586676
40.

Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF.

Blood. 2003 Nov 1;102(9):3085-92. Epub 2003 Jul 17.

PMID:
12869495

Supplemental Content

Loading ...
Support Center